BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Drug Development

  Gilead Sciences, Inc. Announces Phase 2 Results for Sofosbuvir-Based Regimens in Hepatitis C Patients Before and After Liver Transplantation

  November 4, 2013

   · 

  1 min read
• 2013 ISPE Facility of the Year Awards Program Names Novartis AG’s United States Flu Cell Culture Facility as Overall Winner

  November 4, 2013

   · 

  2 min read
• Genetown

  Enanta Pharmaceuticals, Inc. Release: New GT-1b Data From ABT-450 Containing Regimen Being Presented at The Liver Meeting

  November 4, 2013

   · 

  4 min read
• Business

  Addex Therapeutics and National Institute on Drug Abuse (NIDA) Enter Collaboration to Advance ADX71441 & ADX88178 in Drug Abuse and Addiction

  November 4, 2013

   · 

  1 min read
• Policy

  Advanced Medical Isotopes Corporation Files 510(k) Pre-Market Notification for FDA Clearance of Yttrium-90 RadioGel™ Brachytherapy Product

  November 4, 2013

   · 

  1 min read
• Drug Development

  Active Biotech AB’s Partner Teva Pharmaceutical Industries Limited Initiates a Further Clinical Trial in Multiple Sclerosis

  November 4, 2013

   · 

  1 min read
• Drug Development

  Sangamo BioSciences, Inc. Presents Clinical Data From SB-728-T HIV Study Demonstrating Long-Term Immune Reconstitution and Reduction in the HIV DNA Reservoir in Subjects With Long-Term Infection

  November 4, 2013

   · 

  7 min read
• Business

  Jeffrey A. Duchemin Appointed to Additional Roles of President and Director of Harvard Bioscience Inc.

  November 4, 2013

   · 

  1 min read
• Pharm Country

  AngioDynamics to Present at Upcoming Investor Conferences

  November 4, 2013

   · 

  1 min read
• Business

  Thomson Reuters and NuMedii Launch Ground-Breaking Initiative to Identify Drugs for Repurposing

  November 4, 2013

   · 

  4 min read